Feng Xu

机构：Harbin Engineering University · ORCID：0000-0003-0902-2858

发表论文 360 篇 · 总被引 5766 次 · h-index 41

代表论文

• Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 8)
• FNDC5/irisin-enriched sEVs conjugated with bone-targeting aptamer alleviate osteoporosis: a potential alternative to exercise (2025 · Journal of Nanobiotechnology · 被引 7)
• Impact of body composition on vitamin D requirements in healthy adults with vitamin D deficiency (2025 · Frontiers in Endocrinology · 被引 7)
• Pathology-directed drug delivery strategies: How to overcome blood–brain barrier for the treatment of brain diseases (2025 · Acta Pharmaceutica Sinica B · 被引 4)
• Prognostic Utility of a Deep Learning Radiomics Nomogram Integrating Ultrasound and Multi‐Sequence MRI in Triple‐Negative Breast Cancer Treated With Neoadjuvant Chemotherapy (2025 · Journal of Ultrasound in Medicine · 被引 4)
• Adjuvant icotinib for resected EGFR-mutated stage II–IIIA non-small-cell lung cancer (ICTAN, GASTO1002): a randomized comparison study (2025 · Signal Transduction and Targeted Therapy · 被引 4)